{
    "clinical_study": {
        "@rank": "135987", 
        "arm_group": {
            "arm_group_label": "aripiprazole", 
            "description": "Patient group who is treated with aripiprazole"
        }, 
        "brief_summary": {
            "textblock": "-  To estimate dopamine receptor occupancy by aripiprazole using computer simulation\n\n        -  To measure dopamine receptor occupancy by aripiprazole in patients treated with the\n           antipsychotics\n\n        -  To validate the simulation result by comparing the receptor occupancy from the\n           simulation with that from the patients"
        }, 
        "brief_title": "Validation of Receptor Occupancy Simulation", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Dopamine Receptor Occupancy", 
            "Medication Satisfaction", 
            "Prolactin Level", 
            "Schizophrenia"
        ], 
        "condition_browse": {
            "mesh_term": "Schizophrenia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  clinical diagnosis of schizophrenia\n\n          -  treated with aripiprazole or risperidone\n\n          -  no change in dose of antipsychotics for at least 6 weeks\n\n          -  total PANSS score should be below 80\n\n        Exclusion Criteria:\n\n          -  Other psychiatric disorders rather than schizophrenia\n\n          -  history of head trauma\n\n          -  positive in urine hCG\n\n          -  on antidepressant, anticholinergics or mood stabilizer"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with schizophrenia who is in the steady sate of antipsychotic treatment"
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01660880", 
            "org_study_id": "C-1205-094-410", 
            "secondary_id": "A070001"
        }, 
        "intervention_browse": {
            "mesh_term": "Aripiprazole"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 18, 2013", 
        "location": {
            "contact": {
                "email": "euitae.kim@gmail.com", 
                "last_name": "Euitae Kim, M.D., Ph.D.", 
                "phone": "82-10-9419-1058"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Hospital"
            }, 
            "investigator": {
                "last_name": "Euitae Kim, M.D., Ph.D.", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "1", 
        "overall_contact": {
            "email": "euitae.kim@gmail.com", 
            "last_name": "Euitae Kim, M.D., Ph.D.", 
            "phone": "82-10-9419-1058"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Jun Soo Kwon, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measured using 11C-raclopride positron emission tomography", 
            "measure": "Dopamine receptor occupancy", 
            "safety_issue": "No", 
            "time_frame": "72 hrs after the last administration"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01660880"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Jun Soo Kwon", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "HAM-D score", 
                "measure": "Hamilton rating scale for depression", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 72 hours after the last administration"
            }, 
            {
                "description": "BAS score", 
                "measure": "Barnes akathisia scale", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 72 hours after the last administration"
            }, 
            {
                "description": "AIMS score", 
                "measure": "Abnormal involuntary movement scale", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 72 hours after the last administration"
            }, 
            {
                "description": "SAS score", 
                "measure": "Simpson-Angus scale", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 72 hours after the last administration"
            }, 
            {
                "description": "TSQM score", 
                "measure": "Treatment satisfaction questionnaire for medication", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 72 hours after the last administration"
            }, 
            {
                "description": "MSQ score", 
                "measure": "Medication satisfaction questionnaire", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 72 hours after the last administration"
            }, 
            {
                "description": "To measure the change in working memory performance", 
                "measure": "N-back task", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 72 hours after the last administration"
            }, 
            {
                "description": "To explore the effect of receptor occupancy on the blood prolactin level", 
                "measure": "Prolactin level", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 72 hours after the last administration"
            }, 
            {
                "measure": "Dopamine receptor occupancy", 
                "safety_issue": "No", 
                "time_frame": "3 hrs after the last administration"
            }, 
            {
                "measure": "Dopamine receptor occupancy", 
                "safety_issue": "No", 
                "time_frame": "24 hrs after the last administration"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "May 2013"
    }
}